New insights into the regulation of CYP2C9 gene expression: the role of the transcription factor GATA-4

Autor: Ellie Landman, Souren Mkrtchian, Yvonne Hofmann, Isa Cavaco, Jana Nekvindová, Magnus Ingelman-Sundberg, Rasmus Steen Pedersen, Jessica Mwinyi
Přispěvatelé: University of Zurich, Mwinyi, J
Rok vydání: 2009
Předmět:
Chromatin Immunoprecipitation
3003 Pharmaceutical Science
Activation
Pharmaceutical Science
610 Medicine & health
Electrophoretic Mobility Shift Assay
Biology
Transfection
Gene Expression Regulation
Enzymologic

Cytochrome P4502C9
Mice
Genes
Reporter

Cell Line
Tumor

GATA6 Transcription Factor
Gene expression
Transcriptional regulation
Animals
Humans
Cyp19 Expression
Electrophoretic mobility shift assay
Binding site
Promoter Regions
Genetic

Transcription factor
Cytochrome P-450 CYP2C9
Pharmacology
Binding Sites
GATA2
Heart
Hep G2 Cells
Molecular biology
Rat Granulosa-Cells
GATA4 Transcription Factor
DNA-Binding Proteins
GATA2 Transcription Factor
Nuclear Factor-4-Alpha
Transporters
3004 Pharmacology
Hepatocyte-Nuclear-Factor-4-Alpha
Metabolism
10199 Clinic for Clinical Pharmacology and Toxicology
embryonic structures
Mutation
Hepatocytes
GATA transcription factor
Aryl Hydrocarbon Hydroxylases
Polymorphisms
Chromatin immunoprecipitation
Transcription Factors
Zdroj: Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
ISSN: 1521-009X
Popis: CYP2C9 is an important drug-metabolizing enzyme that metabolizes, e. g., warfarin, antidiabetics, and antiphlogistics. However, the endogenous regulation of this enzyme is largely unknown. In this study, we examined the role of GATA transcription factors in the gene expression of CYP2C9. We investigated four putative GATA binding sites within the first 200 base pairs of CYP2C9 promoter at the positions I: -173/-170, II: -167/-164, III: -118/ -115, and IV: -106/-103. Luciferase activity driven by a wildtype CYP2C9 promoter construct was strongly up-regulated in Huh-7 cells upon cotransfection with expression plasmids for GATA-2 and GATA-4, whereas mutations introduced into GATA binding site III or I and II reduced this induction to a significant extent. Electrophoretic mobility shift assays revealed specific binding of GATA-4 and GATA-6 to the oligonucleotides containing GATA binding sites I and II. Furthermore, the association of GATA-4 with CYP2C9 promoter was confirmed by chromatin immunoprecipitation assays in HepG2 cells. Taken together, these data strongly suggest an involvement of liver-specific transcription factor GATA-4 in the transcriptional regulation of CYP2C9. Swedish Research Council; Stockholm County Council; Danish Agency of Science, Technology and Innovation; Lundbeck Foundation; Portuguese Foundation for Science and Technology [SFRH/BPD/34152/2006 IBB/CBME]
Databáze: OpenAIRE